Ranbaxy gets US FDA nod for loratadine tab
Facebook Twitter google+ RSS Feed

Ranbaxy gets US FDA nod for loratadine tab

By SiliconIndia   |   Wednesday, 20 August 2003, 07:00 Hrs
Printer Print Email Email
NEW DELHI: Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to market a generic version of Schering-Plough Corp's anti-allergy Claritin tablets in the 10mg strength, says FDA site www.fda.gov showed.

Ranbaxy had earlier got a tentative nod for the 10 mg loratadine tablets in December 2001. The drug's patent expired last year and it is being sold in the over-the-counter market in the United States by several generic firms, besides the innovator Schering.

Claritin, once a blockbuster drug in Schering's stable, had US sales of $944 million in the 12 months ended June 2003.


Write your comment now
Submit Reset
SPOTLIGHT